Correction: Adjuvant olaparib in the subset of patients from Japan with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trial

Detalles Bibliográficos
Autores principales: Yamauchi, Hideko, Toi, Masakazu, Takayama, Shin, Nakamura, Seigo, Takano, Toshimi, Cui, Karen, Campbell, Christine, De Vos, Liesbet, Geyer, Charles, Tutt, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285017/
https://www.ncbi.nlm.nih.gov/pubmed/37171785
http://dx.doi.org/10.1007/s12282-023-01468-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285017/
https://www.ncbi.nlm.nih.gov/pubmed/37171785
http://dx.doi.org/10.1007/s12282-023-01468-z

Ejemplares similares